Know Cancer

or
forgot password


N/A
20 Years
65 Years
Open (Enrolling)
Both
Renal Cell Carcinoma

Thank you

Trial Information


Inclusion Criteria:



- ASA l and ll

- age 20-65

- patients undergoing partial nephrectomy

Exclusion Criteria:

- preoperative liver or renal dysfunction,

- coagulopathy,

- chronic alcoholism,

- hypersensitivity of NSAID,

- history of warfarin,

- history of gastric ulcer

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

Outcome Measure:

serum creatinine

Outcome Time Frame:

at baseline, 2 hr, 12hr, 24 hr, 48 hr, 72 hr after clamping release

Safety Issue:

No

Authority:

South Korea: Institutional Review Board

Study ID:

4-2012-0485

NCT ID:

NCT01836406

Start Date:

December 2012

Completion Date:

December 2013

Related Keywords:

  • Renal Cell Carcinoma
  • ketorolac
  • remote ischemic preconditioning
  • partial nephrectomy
  • Carcinoma
  • Carcinoma, Renal Cell
  • Reperfusion Injury

Name

Location